EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sex‐Specific Impact of Metabolic Dysfunction‐Associated Fatty Liver Disease on Incident Cardiovascular Diseases and Mortality

Mahsa Abbaszadeh iD, Farhad Hosseinpanah, Maryam Tohidi, Sahar Karimpour Reyhan iD, Maryam Mahdavi, Majid Valizadeh

Endocrinology, Diabetes & Metabolism · 2025-05 · 8 (3)

DOI: 10.1002/edm2.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 26.03.2025. Verfasst von Mahsa Abbaszadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Considering recent revisions in the nomenclature for fatty liver disease, alongside limited data on sex‐specific differences in its cardiovascular/mortality outcomes, this study aims to investigate the prevalence and impact of metabolic‐associated fatty liver disease (MAFLD) on cardiovascular disease (CVD) and mortality in men and women over a 12‐year follow‐up period.

Methods

In this large population‐based cohort study, 7101 individuals aged ≥ 30 were enrolled. The prevalence of MAFLD was investigated in both genders. After excluding individuals with a history of previous CVD, 6331 participants were followed up for CVD and mortality over 12 years. Steatosis was defined as fatty liver index (FLI) ≥ 60. Multivariate‐adjusted hazard ratios (HRs) were calculated for CVD and mortality.

Results

The prevalence of MAFLD was 43.2%, higher in men (46.5%) than women (40.6%). Men with MAFLD (47.7 ± 12.1) were younger than women (52.2 ± 11.1). In the 12‐year follow‐up of 6331 individuals, multivariable‐adjusted CVD HRs for MAFLD were 1.36 (1.10–1.67) in men and 1.48 (1.16–1.88) in women. Adjusted mortality HRs were 1.17 (0.86–1.59) and 1.38 (1.00–1.91) in men and women, respectively. Among patients with MAFLD, a subgroup with diabetes faced the highest hazard for CVD and mortality.

Conclusion

This study found that MAFLD is more common in men at a younger age. Despite the higher prevalence in men, women with MAFLD face a greater risk of cardiovascular events and mortality. Findings highlight the importance of gender‐specific considerations in primary prevention programmes for MAFLD‐related cardiovascular disease and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesNon-alcoholic Fatty Liver DiseaseFatty LiverHumansFemaleMaleMiddle AgedPrevalenceAdultAgedSex FactorsFollow-Up StudiesIncidenceCohort StudiesRisk Factors

Stichwörter der Autor:innen

cardiovascular diseasemetabolic dysfunction‐associated fatty liver diseasesmortalitynon‐alcoholic fatty liver disease

Autor:innen und Institutionen

  • Endocrinology and Metabolism Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Mahsa Abbaszadeh, Sahar Karimpour Reyhan

Zitieren

APA

Abbaszadeh, M., Hosseinpanah, F., Tohidi, M., Karimpour Reyhan, S., Mahdavi, M., & Valizadeh, M. (2025). Sex‐Specific Impact of Metabolic Dysfunction‐Associated Fatty Liver Disease on Incident Cardiovascular Diseases and Mortality. Endocrinology, Diabetes & Metabolism, 8(3). https://doi.org/10.1002/edm2.70035

Vancouver

Abbaszadeh M, Hosseinpanah F, Tohidi M, Karimpour Reyhan S, Mahdavi M, Valizadeh M. Sex‐Specific Impact of Metabolic Dysfunction‐Associated Fatty Liver Disease on Incident Cardiovascular Diseases and Mortality. Endocrinology, Diabetes & Metabolism. 2025;8(3). doi:10.1002/edm2.70035

BibTeX
@article{Abbaszadeh2025,
  author = {Abbaszadeh, Mahsa and Hosseinpanah, Farhad and Tohidi, Maryam and Karimpour Reyhan, Sahar and Mahdavi, Maryam and Valizadeh, Majid},
  title = {Sex‐Specific Impact of Metabolic Dysfunction‐Associated Fatty Liver Disease on Incident Cardiovascular Diseases and Mortality},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2025},
  volume = {8},
  number = {3},
  doi = {10.1002/edm2.70035}
}
Kostenlos starten →